Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice

Experimental Eye Research

Volumn 116, Issue , 2013, Pages 63-74

  Kyosseva, Svetlana V ^a   Chen, Lijuan ^a   Seal, Sudipta ^b   McGinnis, James F ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Age related macular degeneration; Inflammation; Nanoceria; Oxidative stress; PCR array; Vldlr mouse

Indexed keywords

CERIUM OXIDE; COLONY STIMULATING FACTOR 1; EPHRIN A1; EPHRIN A3; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 14; FIBROBLAST GROWTH FACTOR 16; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 5; INTERLEUKIN 11; INTERLEUKIN 23P19; INTERLEUKIN 3; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; LEPTIN; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOSTATIN M; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; THYMIC STROMAL LYMPHOPOIETIN; VASCULOTROPIN A; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL FUNCTIONS; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GENE FUNCTION; INTRACELLULAR SIGNALING; KNOCKOUT GENE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETINITIS; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; UPREGULATION; WESTERN BLOTTING;

AGE RELATED MACULAR DEGENERATION; INFLAMMATION; NANOCERIA; OXIDATIVE STRESS; PCR ARRAY; VLDLR MOUSE;

ANIMALS; BLOTTING, WESTERN; CERIUM; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; INTRAVITREAL INJECTIONS; MALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LDL; RETINA; RETINAL NEOVASCULARIZATION; RETINITIS; RNA;

EID: 84883811012     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.08.003     Document Type: Article

References (75)

1. Adams R.H., Klein R. Eph receptors and ephrin ligands. Essential mediators of vascular development. Trends Cardiovasc. Med. 2000, 10:183-188.
2. Amin R., Puklin J.E., Frank R.N. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1994, 35:3178-3188.
3. Arvanitis D., Davy A. Eph/ephrin signaling: networks. Genes Dev. 2008, 22:416-429.
4. Bando H., Shadrach K.G., Rayborn M.E., Crabb J.W., Hollyfield J.G. Clathrin and adaptin accumulation in drusen, Bruch's membrane and choroid in AMD and non-AMD donor eyes. Exp. Eye Res. 2007, 84:135-142.
5. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45:115-134.
6. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
7. Campa C., Costagliola C., Incorvaia C., Sheridan C., Semeraro F., De N.K., et al. Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. Mediators Inflamm. 2010, 2010.
8. Chen H., Liu B., Lukas T.J., Neufeld A.H. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS ONE 2008, 3:e2339.
9. Chen J., Hicks D., Brantley-Sieders D., Cheng N., McCollum G.W., Qi-Werdich X., et al. Inhibition of retinal neovascularization by soluble EphA2 receptor. Exp. Eye Res. 2006, 82:664-673.
10. Chen J., Patil S., Seal S., McGinnis J.F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nanotechnol. 2006, 1:142-150.
11. Chen Y., Hu Y., Lu K., Flannery J.G., Ma J.X. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J.Biol. Chem. 2007, 282:34420-34428.
12. Chen Y., Hu Y., Moiseyev G., Zhou K.K., Chen D., Ma J.X. Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency. Microvasc. Res. 2009, 78:119-127.
13. Chikama T., Liu C.Y., Meij J.T., Hayashi Y., Wang I.J., Yang L., et al. Excess FGF-7 in corneal epithelium causes corneal intraepithelial neoplasia in young mice and epithelium hyperplasia in adult mice. Am. J. Pathol. 2008, 172:638-649.
14. Chollangi S., Wang J., Martin A., Quinn J., Ash J.D. Preconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina. Neurobiol. Dis. 2009, 34:535-544.
15. Cinaroglu A., Ozmen Y., Ozdemir A., Ozcan F., Ergorul C., Cayirlioglu P., et al. Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina. J.Neurosci. Res. 2005, 79:329-339.
16. Colombo E.S., Menicucci G., McGuire P.G., Das A. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Invest. Ophthalmol. Vis. Sci. 2007, 48:1793-1800.
17. Das M., Patil S., Bhargava N., Kang J.F., Riedel L.M., et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28:1918-1925.
18. Dias J.R., Rodrigues E.B., Maia M., Magalhaes O., Penha F.M., Farah M.E. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy. Br. J. Ophthalmol. 2011, 95:1631-1637.
19. Ding X., Patel M., Chan C.C. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res. 2009, 28:1-18.
20. Dorrell M.I., Aguilar E., Jacobson R., Yanes O., Gariano R., Heckenlively, et al. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. J.Clin. Invest. 2009, 119:611-623.
21. Ehlken C., Martin G., Lange C., Gogaki E.G., Fiedler U., Schaffner F., et al. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy. Acta Ophthalmol. 2011, 89:82-90.
22. Estevez A.Y., Pritchard S., Harper K., Aston J.W., Lynch A., Lucky J.J., et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic. Biol. Med. 2011, 15:1155-1163.
23. Farjo K.M., Ma J.X. The potential of nanomedicine therapies to treat neovascular disease in the retina. J.Angiogenes Res. 2010, 2:21.
24. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
25. Friedman D.S., O'Colmain B.J., Munoz B., Tomany S.C., McCarty C., De Jong P.T., et al. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004, 122:564-572.
26. Frykman P.K., Brown M.S., Yamamoto T., Goldstein J.L., Herz J. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:8453-8457.
27. Fu C.T., Tran T., Sretavan D. Axonal/glial upregulation of EphB/ephrin-B signaling in mouse experimental ocular hypertension. Invest. Ophthalmol. Vis. Sci. 2010, 51:991-1001.
28. Gehrs K.M., Anderson D.H., Johnson L.V., Hageman G.S. Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann. Med. 2006, 38:450-471.
29. Glotin A.L., Calipel A., Brossas J.Y., Faussat A.M., Treton J., Mascarelli F. Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells. Invest. Ophthalmol. Vis. Sci. 2006, 47:4614-4623.
30. Haines J.L., Schnetz-Boutaud N., Schmidt S., Scott W.K., Agarwal A., Postel E.A., et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest. Ophthalmol. Vis. Sci. 2006, 47:329-335.
31. Hayashi M., Hayashi Y., Liu C.Y., Tichelaar J.W., Kao W.W. Over expression of FGF7 enhances cell proliferation but fails to cause pathology in corneal epithelium of Kerapr-rtTA/FGF7 bitransgenic mice. Mol. Vis. 2005, 11:201-207.
32. He R., Oyoshi M.K., Garibyan L., Kumar L., Ziegler S.F., Geha R.S. TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11875-11880.
33. Heckenlively J.R., Hawes N.L., Friedlander M., Nusinowitz S., Hurd R., Davisson M., et al. Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 2003, 23:518-522.
34. Hers I., Vincent E.E., Tavare J.M. Akt signalling in health and disease. Cell Signal 2011, 10:1515-1527.
35. Hirst S.M., Karakoti A.S., Tyler R.D., Sriranganathan N., Seal S., Reilly C.M. Anti-inflammatory properties of cerium oxide nanoparticles. Small 2009, 5:2848-2856.
36. Hollyfield J.G. Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture. Invest. Ophthalmol. Vis. Sci. 2010, 51:1275-1281.
37. Hu W., Criswell M.H., Fong S.L., Temm C.J., Rajashekhar G., Cornell T.L., et al. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development. Exp. Eye Res. 2009, 88:79-91.
38. Hu W., Jiang A., Liang J., Meng H., Chang B., Gao H., et al. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Invest. Ophthalmol. Vis. Sci. 2008, 49:407-415.
39. Hua J., Guerin K.I., Chen J., Michan S., Stahl A., Krah N.M., et al. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. Invest. Ophthalmol. Vis. Sci. 2011, 52:2809-2816.
40. Hubschman J.P., Reddy S., Schwartz S.D. Age-related macular degeneration: experimental and emerging treatments. Clin. Ophthalmol 2009, 3:167-174.
41. Jiang A., Hu W., Meng H., Gao H., Qiao X. Loss of VLDL receptor activates retinal vascular endothelial cells and promotes angiogenesis. Invest. Ophthalmol. Vis. Sci. 2009, 50:844-850.
42. Kanda A., Abecasis G., Swaroop A. Inflammation in the pathogenesis of age-related macular degeneration. Br. J. Ophthalmol. 2008, 92:448-450.
43. Karakoti A., Singh S., Dowding J.M., Seal S., Self W.T. Redox-active radical scavenging nanomaterials. Chem. Soc. Rev. 2010, 39:4422-4432.
44. Karakoti A.S., Monteiro-Riviere N.A., Aggarwal R., Davis J.P., Narayan R.J., Self W.T., et al. Nanoceria as antioxidant: synthesis and biomedical applications. Jom 2008, 60:33-37.
45. King R.E., Kent K.D., Bomser J.A. Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chem. Biol. Interact. 2005, 151:143-149.
46. Kong L., Cai X., Zhou X., Wong L.L., Karakoti A.S., Seal S., et al. Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. Neurobiol. Dis. 2011, 42:514-523.
47. Korsvik C., Patil S., Seal S., Self W.T. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun. (Camb.) 2007, 1056-1058.
48. Kyosseva S.V. Mitogen-activated protein kinase signaling. Int. Rev. Neurobiol. 2004, 59:201-220.
49. Li C., Huang Z., Kingsley R., Zhou X., Li F., Parke D.W., et al. Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation. Arch. Ophthalmol. 2007, 125:795-803.
50. Lip P.L., Blann A.D., Hope-Ross M., Gibson J.M., Lip G.Y. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 2001, 108:705-710.
51. Liu Y.J. Thymic stromal lymphopoietin: master switch for allergic inflammation. J.Exp. Med. 2006, 203:269-273.
52. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
53. Niu J., Azfer A., Rogers L.M., Wang X., Kolattukudy P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc. Res. 2007, 73:549-559.
54. Noelle R.J., Nowak E.C. Cellular sources and immune functions of interleukin-9. Nat. Rev. Immunol. 2010, 10:683-687.
55. Patil S., Seal S., Guo Y., Schulte A., Norwood J. Role of trivalent La and Nd dopants in lattice distortion and oxygen vacancy generation in cerium oxide nanoparticles. Appl. Phys. Lett. 2006, 88:243110.
56. Qazi Y., Maddula S., Ambati B.K. Mediators of ocular angiogenesis. J.Genet. 2009, 88:495-515.
57. Recchia F.M., Xu L., Penn J.S., Boone B., Dexheimer P.J. Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesis. Invest. Ophthalmol. Vis. Sci. 2010, 51:1098-1105.
58. Russell C. The roles of hedgehogs and fibroblast growth factors in eye development and retinal cell rescue. Vision Res. 2003, 43:899-912.
59. Singh S., Kumar A., Karakoti A., Seal S., Self W.T. Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol. Biosyst. 2010, 6:1813-1820.
60. Spilsbury K., Garrett K.L., Shen W.Y., Constable I.J., Rakoczy P.E. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am. J. Pathol. 2000, 157:135-144.
61. Tarnuzzer R.W., Colon J., Patil S., Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano. Lett. 2005, 5:2573-2577.
62. Telander D.G. Inflammation and age-related macular degeneration (AMD). Semin. Ophthalmol. 2011, 26:192-197.
63. Tomita N., Morishita R., Taniyama Y., Koike H., Aoki M., Shimizu H., et al. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 2003, 107:1411-1417.
64. Tsai Y.Y., Lin J.M., Wan L., Lin H.J., Tsai Y., Lee C.C., et al. Interleukin gene polymorphisms in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:693-698.
65. Ueta T., Yanagi Y., Tamaki Y., Yamaguchi T. Cerebrovascular accidents in ranibizumab. Ophthalmology 2009, 116:362.
66. Wang Y., Nakayama M., Pitulescu M.E., Schmidt T.S., Bochenek M.L., Sakakibara A. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 2010, 465:483-486.
67. Winkler B.S., Boulton M.E., Gottsch J.D., Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vis. 1999, 5:32.
68. Wong L.L., Hirst S.M., Pye Q.N., Reilly C.M., Seal S., McGinnis J.F. Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection. PLosOne 2013, 8:e58431.
69. Xia C.H., Lu E., Liu H., Du X., Beutler B., Gong X. The role of Vldlr in intraretinal angiogenesis in mice. Invest. Ophthalmol. Vis. Sci. 2011, 52:6572-6579.
70. Yannuzzi L.A., Negrao S., Iida T., Carvalho C., Rodriguez-Coleman H., Slakter J., et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001, 21:416-434.
71. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 2004, 122:598-614.
72. Zarbin M.A., Rosenfeld P.J. Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives. Retina 2010, 30:1350-1367.
73. Zheng X., Ma P., de Paiva C.S., Cunningham M.A., Hwang C.S., Pflugfelder S.C., et al. TSLP and downstream molecules in experimental mouse allergic conjunctivitis. Invest. Ophthalmol. Vis. Sci. 2010, 51:3076-3082.
74. Zhou X., Wong L.L., Karakoti A.S., Seal S., McGinnis J.F. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the vldlr knockout mouse. PLos ONE 2011, 6:e16733.
75. Zhou Y., Yan H., Guo M., Zhu J., Xiao Q., Zhang L. Reactive oxygen species in vascular formation and development. Oxid. Med. Cell Longev. 2013, 2013:374963.